Use of Prostaglandin E1 to Treat Atheromatous Embolization

Parodi, Juan C.
November 2005
Vascular;Nov2005 Supplement, Vol. 13, pS122
Academic Journal
This article focuses on the use of prostaglandin E1 (PGE1) to treat atheromatous embolization. Aside from having potent vasodilatation effect, other actions of PGE1 include the inhibition of platelet and leucocyte activation, deaggregation of platelet and leucocyte aggregates, induction of angiogenesis and an ill-defined action of cell membrane stabilization. The causes of distal embolization are identified.


Related Articles

  • Protruding atheromas in the thoracic aorta and systemic embolization. Tunick, Paul T.; Perez, John L.; Kronzon, Itzhak; Tunick, P A; Perez, J L; Kronzon, I // Annals of Internal Medicine;9/15/91, Vol. 115 Issue 6, p423 

    Objective: To determine whether protruding atheromas in the thoracic aorta are a risk factor for systemic embolization.Design: Case-control study.Setting: A referral hospital.Patients: A total of 122 patients with a history of stroke, transient...

  • Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model. Wanjun Bai; Xue Zheng; Liaosheng Zhou; Hongjian Li // Canadian Journal of Physiology & Pharmacology;Feb2012, Vol. 90 Issue 2, p131 

    This study evaluated the effect of prostaglandin E1 (PGE1) on the stability of atherosclerotic plaque. A vulnerable plaque model was established in rabbits, using balloon injury combined with a high-cholesterol diet. The rabbits were distributed into a control group, a low-dose PGE1 treatment...

  • Lowered microvascular vessel wall oxygen consumption augments tissue pO2 during PgE1-induced vasodilation. Friesenecker, Barbara; Tsai, A. G.; Dünser, M. W.; Martini, J.; Hasibeder, W.; Intaglietta, M.; Dünser, M W // European Journal of Applied Physiology;Mar2007, Vol. 99 Issue 4, p405 

    Continuous infusion of intravenous prostaglandin E1 (PgE1, 2.5 mug/kg/min) was used to determine how vasodilation affects oxygen consumption of the microvascular wall and tissue pO(2) in the hamster window chamber model. While systemic measurements (mean arterial pressure and heart rate) and...

  • Analysis of Alprostadil by HPLC with Post-Column Derivatization.  // LC-GC North America;Dec2014 Supplement, Vol. 32, p68 

    The article offers information on the research related to drug alprostadil which has vasodilation properties. Topics related to the drug that are discussed includes ultraviolet absorbance, analytical conditions, calibration and its suppository form. It also presents various graphs of the drug...

  • Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Chung N A; Lydakis C; Belgore F; Li-Saw-Hee F L; Blann A D; Lip G Y H // Heart;Dec2003, Vol. 89 Issue 12, p1411 

    BACKGROUND: Thrombogenesis, angiogenesis, and endothelial damage/dysfunction are components in the pathogenesis of atherosclerosis. OBJECTIVE: To investigate the relation of these variables to atherosclerotic disease severity and the possible interrelations between the three. METHODS: 111...

  • Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Arbustini, E.; Morbini, P.; D'Armini, A.M.; Repetto, A.; Minzioni, G.; Piovella, F.; Viganò, M.; Tavazzi, L. // Heart;Aug2002, Vol. 88 Issue 2, p177 

    Discusses results of a study comparing plaque composition in plexogenic and thromboembolic pulmonary hypertension. Types of intimal lesions; Glycophorin immunoreactive material; Incidence of angiogenesis; Localization of atheromatous cores.

  • Monocyte influx supports the proliferation of angiogenic microvessels under ischemic and inflammatory conditions. Woodfin, A.; Ma, B.; Nourshargh, S. // Proceedings of the Physiological Society;2013, p61P 

    Angiogenesis is a common feature of chronic inflammatory and ischemic conditions, and is both driven by, and contributory to, the eventual pathological outcomes. An example of this can be seen in the development of atherosclerotic plaques, where neovascularisation facilitates monocyte...

  • Pulmonary hypertension due to unknown causes in liver resection. Egawa, Junji; Inoue, Satoki; Shinjo, Takeaki; Furuya, Hitoshi // Journal of Anesthesia;2007, Vol. 21 Issue 4, p513 

    A 16-year-old male underwent transcatheter arterial embolization against a large hepatic tumor, and was subsequently scheduled for removal of the tumor. Sudden hypotension and tachycardia were observed on removal of the tumor. Massive bleeding or obstruction of the inferior vena cava was...

  • Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions. Li Xing; Kurumbail, Ravi G.; Frazier, Ronald B.; Davies, Michael S.; Fujiwara, Hideji; Weinberg, Robin A.; Gierse, James K.; Caspers, Nicole; Carter, Jeffrey S.; McDonald, Joseph J.; Moore, William M.; Vazquez, Michael L. // Journal of Computer-Aided Molecular Design;Jan2009, Vol. 23 Issue 1, p13 

    Inducible, microsomal prostaglandin E synthase 1 (mPGES-1), the terminal enzyme in the prostaglandin (PG) biosynthetic pathway, constitutes a promising therapeutic target for the development of new anti-inflammatory drugs. To elucidate structure�function relationships and to enable...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics